-transparent.png){kind=logo}
Cytembena has been shown to undergo a rapid addition reaction with a number of thiol compounds, including glutathione and cysteine, resulting in alkylation of the sulphur. Administration of Cytembena to Yoshida sarcoma cells and to L1210 leukemia cells resulted in a loss of titratable thiol groups within the cells, though the loss of thiol groups caused by pharmacologically active doses of the drug was not sufficient to account, in itself, for the observed toxicity. The addition product of Cytembena and glutathione was isolated and tested for cytotoxicity; it was much less effective than free Cytembena. It is concluded that this reaction acts as a route of detoxification of Cytembena.
R C Jackson, and
G A Taylor, and
K R Harrap
January 1957,
Biochimica et biophysica acta,
R C Jackson, and
G A Taylor, and
K R Harrap
January 1946,
Federation proceedings,
R C Jackson, and
G A Taylor, and
K R Harrap
August 1946,
The Journal of biological chemistry,
R C Jackson, and
G A Taylor, and
K R Harrap
January 1956,
Archivum immunologiae et therapiae experimentalis,
R C Jackson, and
G A Taylor, and
K R Harrap
February 1979,
The Biochemical journal,
R C Jackson, and
G A Taylor, and
K R Harrap
June 1969,
Thrombosis et diathesis haemorrhagica,
R C Jackson, and
G A Taylor, and
K R Harrap
February 1965,
The Biochemical journal,
R C Jackson, and
G A Taylor, and
K R Harrap
October 1998,
Lipids,
R C Jackson, and
G A Taylor, and
K R Harrap
January 2016,
Anti-cancer agents in medicinal chemistry,
R C Jackson, and
G A Taylor, and
K R Harrap
March 1962,
The Biochemical journal,
